Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers

被引：0
|
作者：
Lee, Jaeyop [1 ]
Ku, Geoffrey [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 03期
关键词：
HER2; Esophagogastric cancer; Trastuzumab; Antibody drug conjugate; Immune modulation; Immunotherapy; Targeted therapy; ANTIBODY-DRUG CONJUGATE; GASTROESOPHAGEAL JUNCTION CANCER; GASTRIC-CANCER; TRASTUZUMAB DERUXTECAN; ADVANCED BREAST; HER2; STATUS; SINGLE-ARM; OPEN-LABEL; LAPATINIB; COMBINATION;
D O I：
10.1016/j.hoc.2024.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：585 / 598
页数：14
相关论文
共 50 条
  • [21] Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy
    Li, Zhensheng
    Chen, Liang
    Han, Huina
    Shang, Yuguang
    Li, Yue
    Jia, Zhifeng
    Liu, Yunjiang
    ONCOLOGY RESEARCH AND TREATMENT, 2024,
  • [22] Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2-Targeted Therapy
    Chudnovsky, Yakov
    Kumar, Runjun D.
    Schrock, Alexa B.
    Connelly, Caitlin
    Gowen, Kyle
    Frampton, Garrett M.
    Erlich, Rachel L.
    Stephens, Philip J.
    Miller, Vincent A.
    Ross, Jeffrey S.
    Ali, Siraj M.
    Bose, Ron
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 9
  • [23] Re: Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor-targeted therapy
    Ferretti, Gianluigi
    Felici, Alessandra
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (21): : 1644 - 1644
  • [24] Survival among elderly breast cancer patients by receipt of human epidermal growth factor receptor 2-targeted therapy: A matched analysis of national registry data.
    Rogerio, Jaqueline Willemann
    Hao, Yanni
    Huang, Huan
    Lin, Iris
    Menzin, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
    Shen, Le-Sang
    Jin, Xiao-Yan
    Wang, Xu-Meng
    Tou, Lai-Zhen
    Huang, Jian
    CHINESE MEDICAL JOURNAL, 2020, 133 (09) : 1099 - 1108
  • [26] Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
    Saito, Ayumi
    Yoshida, Hiroshi
    Nishikawa, Tadaaki
    Yonemori, Kan
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (10): : 868 - 881
  • [27] The epidermal growth factor receptor as a target for gastrointestinal cancer therapy
    Tedesco K.L.
    Lockhart A.C.
    Berlin J.D.
    Current Treatment Options in Oncology, 2004, 5 (5) : 393 - 403
  • [28] Resistance to epidermal growth factor receptor-targeted therapy
    Morgillo, F
    Lee, HY
    DRUG RESISTANCE UPDATES, 2005, 8 (05) : 298 - 310
  • [29] Targeted therapy against the epidermal growth factor receptor - Introduction
    Herbst, RS
    Hong, WK
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 1 - 2
  • [30] The epidermal growth factor receptor pathway: A model for targeted therapy
    Scaltriti, Maurizio
    Baselga, Jose
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5268 - 5272
12345